ISSN : 0975-5276
EISSN : 0975-9174
B.C. PATEL1*, C.P. KUKADIA2, S.T. SONI3, D.G. TADA4, M.M. VEGAD5
1Department of Microbiology, B.J. Medical College, Ahmedabad, 380016, Gujarat, India
2Department of Microbiology, B.J. Medical College, Ahmedabad, 380016, Gujarat, India
3Department of Microbiology, B.J. Medical College, Ahmedabad, 380016, Gujarat, India
4Department of Microbiology, B.J. Medical College, Ahmedabad, 380016, Gujarat, India
5Department of Microbiology, B.J. Medical College, Ahmedabad, 380016, Gujarat, India
* Corresponding Author : drbhavika9312@gmail.com
Received : 09-12-2017 Accepted : 23-12-2017 Published : 28-12-2017
Volume : 9 Issue : 12 Pages : 990 - 992
Int J Microbiol Res 9.12 (2017):990-992
Keywords : UTI, Antibiotic, Nitrofurantoin, Gram-negative bacteria
Academic Editor : S. Dugal, Habib Zarredar
Conflict of Interest : None declared
Acknowledgements/Funding : Authors are thankful to Department of Microbiology, B.J. Medical College, Ahmedabad, 380016, Gujarat, India
Author Contribution : All author equally contributed
Urinary tract infections (UTIs) remain the common infections diagnosed in outpatients as well as hospitalized patients. Knowledge on antimicrobial susceptibility pattern is essential for appropriate therapy. The aim of this study was to describe pathogens frequency and their resistance patterns.5377 samples were received and proceed, out of them 1701 (31.63%) were positive among which the most prevalent were E. coli (44.97%) followed by Klebsiella species. (21.81%), & Pseudomonas species (13.69%). Furthermore, we had a high percentage of samples from people aged 46-60 and aged less than 15, predominantly women. Among the gram-negative enteric bacilli high prevalence of resistance was observed against many antimicrobial agents. This study revealed that E. coli were the predominant bacterial pathogen of UTIs in Ahmedabad, India. This study is useful for clinician in order to improve the empiric treatment and case management of UTIs.
1. Hooton T.M. (2012) Engl J Med., 366,1028-37.
2. Hsueh P.R., Hoban D.J., Carmeli Y., Chen S.Y., Desikan S. and Alejandria M. (2011) J Infect., 63, 114-23.
3. Saadeh S.A. and Mattoo T.K. (2011) Pediatr Nephrol., 26(11),1967- 76.
4. Akram M., Shahid M. and Khan A.U. (2007) A Clin Microbiol Antimicrob., 6, 4.
5. Braoios A., Turatti T.F., Meredija L.C.S. and Campos T.R.S. (2009) Med Lab., 45, 449-56.
6. Kiffer C.R., Camargo E.C., Shimakura S.E., Ribeiro P.J. Jr, Bailey T.C., Pignatari A.C., et al. (2011) Int J Health Geogr.,10,17.
7. Andrade S.S., Sader H.S., Jones R.N., Pereira A.S., Pignatari A.C. and Gales A.C. (2006) Mem Inst Oswaldo Cruz., 101,741-8.
8. Kiffer C.R., Mendes C., Oplustil C.P. and Sampaio J.L. (2007) Int Braz J Urol., 33, 428.
9. Rocha J.L., Tuon F.F. and Johnson J.R. (2012) Braz J Infect Dis., 16,115-21.
10. Amudavalli K. and Amudhan Arvind E. (2017) European Journal of Biomedical and Pharmaceutical sciences, 4(8), 768-770.
11. de Lucas Collantes C., Cela Alvargonzalez J., Angulo Chacon A.M., Garcia Ascaso M., Pineiro Perez R., Cilleruelo Ortega M.J., et al. (2012) An Pediatr (Barc)., 76, 224-8.
12. Mody L. and Juthani-Mehta M. (2014) Jama., 311,844-54.
13. Kashanian J., Hakimian P., Blute M. Jr, Wong J., Khanna H. and Wise G. (2008) BJU Int., 102, 1634-7.
14. Michalopoulos A.S., Livaditis I.G. and Gougoutas V. (2011) Int J Infect Dis., 15, e732-9.
15. Raz R. (2012) Clin Microbiol Infect., 18(1):4-7.
16. Killgore K.M., March K.L. and Guglielmo B.J. (2004) Ann Pharmacother. 38,1148-52.
17. Gupta K., Hooton T.M., Naber K.G., Wullt B., Colgan R., Miller L.G., et al. (2011) Clin Infect Dis., 52, e103-20.
18. Mittendorf R., Williams M.A. and Kass E.H. (1992) Clin Infect Dis., 14,927-32.
19. Smaill FM and Vazquez JC. (2015) Cochrane Database Syst Rev., 8, Cd000490.
20. Mirella Alves Cunha, Gabriela Lins Medeiros Assunção, Iara Marques Medeiros, and Marise Reis Freitas (2016) Rev Inst Med Trop Sao Paulo, 58, 2.
21. Asmunds Dottir L.R., Erlends Dottir H. and Gott Fredsson M. (2002) J Clin Microbiol., 40, 3489‐92.